Expression profiling of the genes responding to zearalenone and its analogues using estrogen-responsive genes

FEBS Lett. 2009 Jul 21;583(14):2377-84. doi: 10.1016/j.febslet.2009.06.035. Epub 2009 Jun 23.

Abstract

To compare gene expression profiles in response to estrogen or 17beta-estradiol (E(2)) and a mycotoxin, zearalenone (ZEA), and its analogues (collectively termed ZEA compounds), breast cancer MCF-7 cells were treated with 10 nM of E(2) or ZEA compounds including ZEA, alpha-zearalenol, beta-zearalenol, zearalanone, alpha-zearalanol and beta-zearalanol. Expression profiles for 120 estrogen-responsive genes were subjected to cluster and statistical analyses using correlation coefficients or R-values. We found that all of the ZEA compounds stimulated the growth of MCF-7 cells, as much as E(2), and showed similar expression profiles to that of E(2) (R-values ranged from 0.82 to 0.96). The effect of ZEA compounds was likely mediated by estrogen-receptor-dependent Erk1/2-signaling. These results provide clues to understand the mechanism of their estrogen-like action.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms / metabolism
  • Cell Line, Tumor / drug effects
  • Dose-Response Relationship, Drug
  • Enzyme Activation
  • Estradiol / pharmacology
  • Estrogens / pharmacology
  • Estrogens, Non-Steroidal / chemistry
  • Estrogens, Non-Steroidal / pharmacology*
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Female
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic / drug effects*
  • Humans
  • Molecular Structure
  • Oligonucleotide Array Sequence Analysis
  • Receptors, Estrogen / metabolism
  • Signal Transduction / drug effects
  • Zearalenone* / analogs & derivatives
  • Zearalenone* / pharmacology

Substances

  • Estrogens
  • Estrogens, Non-Steroidal
  • Receptors, Estrogen
  • Estradiol
  • Zearalenone
  • Extracellular Signal-Regulated MAP Kinases